Normal view MARC view ISBD view

Formulation Development Optimization and Stabilization of Olmesartan Medoxomil Immediate Release Tablet for Hypertension

By:

Material type: Text

TextPublication details: Ahmedabad Institute of Pharmacy, Nirma University 2016Description: 206pDDC classification:

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre Reference	Reference	615.4 SHA (Browse shelf(Opens below))	Not For Loan		PDR00398
CD/DVD	NIMA Knowledge Centre Reference	Reference	615.4 SHA (Browse shelf(Opens below))	Not For Loan		PDR00398-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.4 SAV Gene Therapy for Neurodegenerative Diseases	615.4 SHA Preparation and Evaluation of Dry Powder Inhaler (DPI) Formulation for Fixed Dose Combination of Bronchodilators	615.4 SHA Preparation and Evaluation of Dry Powder Inhaler (DPI) Formulation for Fixed Dose Combination of Bronchodilators	615.4 SHA Formulation Development Optimization and Stabilization of Olmesartan Medoxomil Immediate Release Tablet for Hypertension	615.4 SHA Formulation Development Optimization and Stabilization of Olmesartan Medoxomil Immediate Release Tablet for Hypertension	615.4 SHA Development of Ligand Appended Lipid Nanoparticulate Systems of Anti-Cancer Agent for the Treatment of Colorectal Cancer	615.4 SHA Development of Ligand Appended Lipid Nanoparticulate Systems of Anti-Cancer Agent for the Treatment of Colorectal Cancer	Next

Guided by Dr. Tejal Mehta and Dr. Mukesh Patel

There are no comments on this title.

to post a comment.